These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 6251327)
21. Catecholamines and neurologic diseases (second of two parts). Moskowitz MA; Wurtman RJ N Engl J Med; 1975 Aug; 293(7):332-8. PubMed ID: 125386 [No Abstract] [Full Text] [Related]
22. Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors. Muller P; Seeman P Life Sci; 1977 Dec; 21(12):1751-8. PubMed ID: 203807 [No Abstract] [Full Text] [Related]
23. Quantitative autoradiography of neurotransmitter receptors in Huntington disease. Penney JB; Young AB Neurology; 1982 Dec; 32(12):1391-5. PubMed ID: 6292789 [TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of membrane drug receptors. Gourley DR Prog Drug Res; 1976; 20():323-46. PubMed ID: 189353 [No Abstract] [Full Text] [Related]
25. Stress, endorphins and psychosis. A hypothesis. Amir S; Amit Z; Brown ZW Mod Probl Pharmacopsychiatry; 1981; 17():192-201. PubMed ID: 6276725 [No Abstract] [Full Text] [Related]
26. Biochemical characterization of the muscarinic cholinergic receptor in human brain: alterations in Huntington's disease. Wastek GJ; Yamamura HI Mol Pharmacol; 1978 Sep; 14(5):768-80. PubMed ID: 152407 [No Abstract] [Full Text] [Related]
27. Cholinergic circuits and signaling in the pathophysiology of schizophrenia. Berman JA; Talmage DA; Role LW Int Rev Neurobiol; 2007; 78():193-223. PubMed ID: 17349862 [TBL] [Abstract][Full Text] [Related]
28. Somatostatin alterations and brain diseases. Epelbaum J; Agid Y; Enjalbert A; Hamon M; Javoy-Agid F; Kordon C; Lamour Y; Moyse E Adv Exp Med Biol; 1985; 188():261-74. PubMed ID: 2863935 [No Abstract] [Full Text] [Related]
31. [The role of GABA neurons in some neurological and psychiatric disorders (author's transl)]. Pericić D Lijec Vjesn; 1979 Sep; 101(9):541-6. PubMed ID: 161601 [No Abstract] [Full Text] [Related]
32. [Dementia and psychotic disorders in parkinsonism: common origin and new perspectives in therapy]. Litvinenko IV Adv Gerontol; 2004; 13():94-101. PubMed ID: 15490731 [TBL] [Abstract][Full Text] [Related]
33. Alterations in the benzodiazepine receptor of Huntington's diseased human brain. Reisine TD; Wastek GJ; Speth RC; Bird ED; Yamamura HI Brain Res; 1979 Apr; 165(1):183-7. PubMed ID: 34467 [No Abstract] [Full Text] [Related]
34. Receptor occupancy dose--response curve suggests that phosphatidyl-inositol breakdown may be intrinsic to the mechanism of the muscarinic cholinergic receptor. Michell RH; Jafferji SS; Jones LM FEBS Lett; 1976 Oct; 69(1):1-5. PubMed ID: 992019 [No Abstract] [Full Text] [Related]
35. Neurotransmitter receptor alterations in Parkinson's disease. Reisine TD; Fields JZ; Yamamura HI Life Sci; 1977 Aug; 21(3):335-43. PubMed ID: 197361 [No Abstract] [Full Text] [Related]
36. Neurology and psychopharmacology. Merskey H Mod Trends Neurol; 1975; 6():241-7. PubMed ID: 127928 [No Abstract] [Full Text] [Related]
37. Interaction of phencyclidines with the muscarinic and opiate receptors in the central nervous system. Vincent JP; Cavey D; Kamenka JM; Geneste P; Lazdunski M Brain Res; 1978 Aug; 152(1):176-82. PubMed ID: 79434 [No Abstract] [Full Text] [Related]